#USA #Boston #Ginkgo Bioworks #Nebula #Araceli Biosciences

Araceli Biosciences and Ginkgo Bioworks Integrate Cutting-Edge Imaging for Drug Discovery

In an exciting advancement for the biomedical field, Araceli Biosciences has partnered with Ginkgo Bioworks to incorporate their Endeavor® high-content imaging system into ``Nebula``, Ginkgo's innovative autonomous laboratory located in Boston. This collaboration aims to enhance the pace and reliability of drug discovery processes through high-speed cellular imaging.

The Endeavor® Imaging System

The Endeavor® is recognized as the fastest high-content imaging instrument globally, enabling researchers to capture and analyze cellular images rapidly. This state-of-the-art system can image a 1536-well plate in less than four minutes, ensuring that researchers receive timely and curated datasets essential for training and refining AI models used in drug discovery. By integrating this imaging system into Nebula, scientists can benefit from real-time analysis, significantly reducing turnaround times and expediting the research process.

A New Era of Autonomous Laboratories

Built on Ginkgo's Reconfigurable Automation Carts (RACs), Nebula serves as a paradigm shift from traditional laboratory environments. These RACs combine intelligent robotic arms and automated sample transport systems alongside unified control software. This modular approach allows procedures and technologies to be adapted dynamically based on evolving research needs. With over 100 RACs in operation, daily research activities can advance with minimal human intervention, thus enhancing productivity and reducing operational costs.

Real-Time Quality Control with ClaireRT™

The integration of Araceli's ClaireRT™ software further enhances the capabilities of the Endeavor® system. This software facilitates continuous real-time monitoring, analyzing images immediately as they are captured. If any wells fail to meet specified criteria, the system can alert the operators or halt the imaging process, allowing for immediate corrective actions before ongoing experiments proceed. This level of control not only ensures data integrity but also enables proactive responses to experimental challenges.

Statement from Industry Leaders

Matt Beaudet, the President and CEO of Araceli Biosciences, articulated the significance of this innovation: "The next generation of AI in drug discovery needs a completely different scale of biological data. The lab itself is changing. It now generates cellular data, interprets what it sees, and responds in real-time. Ginkgo is paving the way with Nebula, and Araceli's high-content imaging enriches that ecosystem on an unprecedented scale."

Similarly, Jason Kelly, co-founder and CEO of Ginkgo Bioworks, expressed his enthusiasm for this partnership, stating, "An autonomous lab gets more valuable every time you add a best-in-class instrument to it. With your own autonomous lab, any of your scientists can access the Endeavor's high-content imaging capabilities and connect effortlessly to all of your other instruments, creating a comprehensive biology toolkit within a singular operational framework."

Future Implications

As drug discovery continues to evolve, the need for efficient and high-quality data becomes more critical. The collaboration between Araceli Biosciences and Ginkgo Bioworks represents a major leap towards fulfilling this need and setting new benchmarks in the biopharmaceutical industry. The integrated labs provide a blueprint for other organizations, emphasizing the importance of innovation and collaboration in scientific research.

As this technology gains traction, the implications for biotechnology and pharmaceuticals could be profound, ultimately leading to faster delivery of drugs and therapies while significantly lowering research and development costs. It will be intriguing to see how this partnership further develops and influences the future of biomedical research.

For additional insights into the capabilities of Araceli Biosciences and Ginkgo Bioworks, or to explore future partnerships in scientific innovation, visit their respective websites to learn more about their offerings and research initiatives.